However, more studies on repeated measurements of Lp(a) after myocardial infarction are needed to investigate changes in Lp(a) levels during and after cardiovascular events, as shifts in risk profiles are likely to occur, potentially influencing treatment initiation [5]. This evidence concerns the gene LPA and myocardial infarction.